BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tse G, Gong M, Li G, Wong SH, Wu WKK, Wong WT, Roever L, Lee APW, Lip GYH, Wong MCS, Liu T; International Health Informatics Study (IHIS) Network. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 2018;84:1868-82. [PMID: 29704269 DOI: 10.1111/bcp.13621] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Yu J, Kuang Y, Wu C, Yang L, Fang Q, Pei Q, Yang G. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study. Curr Med Res Opin 2020;36:1433-9. [PMID: 32677855 DOI: 10.1080/03007995.2020.1796611] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Alwafi H, Wei L, Naser AY, Mongkhon P, Tse G, Man KKC, Bell JS, Ilomaki J, Fang G, Wong ICK. Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK. BMJ Open 2020;10:e034573. [PMID: 32414823 DOI: 10.1136/bmjopen-2019-034573] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Pal N, Kertai MD. Perioperative Precision Medicine: Where Are We in 2020? Curr Opin Anaesthesiol 2020;33:463-74. [PMID: 32371636 DOI: 10.1097/ACO.0000000000000858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Panchenko E, Kropacheva E, Dobrovolsky A, Titaeva E, Zemlyanskaya O, Trofimov D, Galkina I, Lifshits G, Vereina N, Sinitsin S, Vorobyeva N, Grehova L, Zateyshchikov D, Zotova I, Vavilova T, Sirotkina O, Grontkovskaya A. CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients. Pharmacogenomics J 2020;20:687-94. [DOI: 10.1038/s41397-020-0157-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shah RR. Genotype‐guided warfarin therapy: Still of only questionable value two decades on. J Clin Pharm Ther 2020;45:547-60. [DOI: 10.1111/jcpt.13127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Helin TA, Joutsi-Korhonen L, Asmundela H, Niemi M, Orpana A, Lassila R. Warfarin dose requirement in patients having severe thrombosis or thrombophilia. Br J Clin Pharmacol 2019;85:1684-91. [PMID: 30933373 DOI: 10.1111/bcp.13948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Koshy L, Harikrishnan S, Sudhakaran PR. Prioritizing rs7294 as a mirSNP contributing to warfarin dosing variability. Pharmacogenomics 2020;21:257-67. [PMID: 31973625 DOI: 10.2217/pgs-2019-0137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Asiimwe IG, Zhang EJ, Osanlou R, Jorgensen AL, Pirmohamed M. Warfarin dosing algorithms: A systematic review. Br J Clin Pharmacol 2021;87:1717-29. [PMID: 33080066 DOI: 10.1111/bcp.14608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Sridharan K, Sequeira RP. Comment on 'Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized clinical trials' by Tse et al. Br J Clin Pharmacol 2018;84:2162-4. [PMID: 29876946 DOI: 10.1111/bcp.13648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sabry S, El Wakeel LM, Saleh A, Ahmed MA. Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized Trial. Clin Drug Investig 2022. [PMID: 35274222 DOI: 10.1007/s40261-022-01137-7] [Reference Citation Analysis]
11 Asiimwe IG, Pirmohamed M. Ethnic Diversity and Warfarin Pharmacogenomics. Front Pharmacol 2022;13:866058. [PMID: 35444556 DOI: 10.3389/fphar.2022.866058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xie C, Xue L, Zhang Y, Zhu J, Zhou L, Hang Y, Ding X, Jiang B, Miao L. Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients. Pharmacogenomics 2020;21:23-32. [PMID: 31849278 DOI: 10.2217/pgs-2019-0124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Wang Y, Lv H, Li D, Chen C, Gu G, Sun Y, Yang X, Liu Y, Fang F, Liu J, Tse G, Xia Y. Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies. Front Pharmacol 2019;10:773. [PMID: 31354488 DOI: 10.3389/fphar.2019.00773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Tse G, Gong M, Li G, Wong SH, Wu WKK, Wong WT, Roever L, Lee APW, Lip GYH, Wong MCS, Liu T; International Health Informatics Study (IHIS) Network. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 2018;84:1868-82. [PMID: 29704269 DOI: 10.1111/bcp.13621] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
15 Arakelyan MG, Bockeria LA, Vasilieva EY, Golitsyn SP, Golukhova EZ, Gorev MV, Davtyan KV, Drapkina OM, Kropacheva ES, Kuchinskaya EA, Lajovich LY, Mironov NY, Mishina IE, Panchenko EP, Revishvili AS, Rzayev FG, Tatarsky BA, Utsumueva MD, Shakhmatova OO, Shlevkov NB, Shpektor AV, Andreev DA, Artyukhina EA, Barbarash OL, Galyavich AS, Duplyakov DV, Zenin SA, Lebedev DS, Mikhailov EN, Novikova NA, Popov SV, Filatov AG, Shlyakhto EV, Shubik YV. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter. Russ J Cardiol 2021;26:4594. [DOI: 10.15829/1560-4071-2021-4594] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 19.0] [Reference Citation Analysis]
16 Wang X, Tang B, Zhou M, Liu L, Feng X, Wang X, Qiu K. Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials. Thromb Res 2021;210:42-52. [PMID: 34999431 DOI: 10.1016/j.thromres.2021.12.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tse G, Roever L, Wong MCS, Lip GYH, Liu T; International Health Informatics Study (IHIS) Network. Reply to 'Comment on 'Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized clinical trials' by Tse et al.'. Br J Clin Pharmacol 2018;84:2165-6. [PMID: 29984539 DOI: 10.1111/bcp.13658] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 He J, Xie H, Yan C, Sun Y, Xu Z, Zhang X. Genetic Variation in VKORC1 and Risk for Osteoporosis. Arch Med Res 2021;52:211-6. [PMID: 33234259 DOI: 10.1016/j.arcmed.2020.10.008] [Reference Citation Analysis]
19 Yang T, Zhou Y, Chen C, Lu M, Ma L, Cui Y. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials. J Clin Pharm Ther 2019;44:197-208. [DOI: 10.1111/jcpt.12782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]